Jill Carroll - Net Worth and Insider Trading
Jill Carroll Net Worth
The estimated net worth of Jill Carroll is at least $213 Million dollars as of 2024-05-05. Jill Carroll is the Director, 10% Owner of Pandion Therapeutics Inc and owns about 2,248,304 shares of Pandion Therapeutics Inc (PAND) stock worth over $135 Million. Jill Carroll is also the Director of Arcellx Inc and owns about 1,479,148 shares of Arcellx Inc (ACLX) stock worth over $78 Million. Details can be seen in Jill Carroll's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jill Carroll has not made any transactions after 2024-03-21 and currently still holds the listed stock(s).
Transaction Summary of Jill Carroll
Jill Carroll Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jill Carroll owns 3 companies in total, including Pandion Therapeutics Inc (PAND) , Applied Genetic Technologies Corp (AGTC) , and Arcellx Inc (ACLX) .
Click here to see the complete history of Jill Carroll’s form 4 insider trades.
Insider Ownership Summary of Jill Carroll
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PAND | Pandion Therapeutics Inc | 2020-07-21 | director & 10 percent owner |
| AGTC | Applied Genetic Technologies Corp | 2014-03-26 | director & 10 percent owner |
| ACLX | Arcellx Inc | 2024-03-21 | director |
Jill Carroll Latest Holdings Summary
Jill Carroll currently owns a total of 2 stocks. Among these stocks, Jill Carroll owns 2,248,304 shares of Pandion Therapeutics Inc (PAND) as of July 21, 2020, with a value of $135 Million and a weighting of 63.4%. Jill Carroll also owns 1,479,148 shares of Arcellx Inc (ACLX) as of March 21, 2024, with a value of $78 Million and a weighting of 36.6%.
Latest Holdings of Jill Carroll
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PAND | Pandion Therapeutics Inc | 2020-07-21 | 2,248,304 | 60.05 | 135,010,655 |
| ACLX | Arcellx Inc | 2024-03-21 | 1,479,148 | 52.69 | 77,936,308 |
Holding Weightings of Jill Carroll
Jill Carroll Form 4 Trading Tracker
According to the SEC Form 4 filings, Jill Carroll has made a total of 1 transactions in Pandion Therapeutics Inc (PAND) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pandion Therapeutics Inc is the acquisition of 361,111 shares on July 21, 2020, which cost Jill Carroll around $7 Million.
According to the SEC Form 4 filings, Jill Carroll has made a total of 4 transactions in Arcellx Inc (ACLX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Arcellx Inc is the sale of 504,263 shares on March 21, 2024, which brought Jill Carroll around $36 Million.
Insider Trading History of Jill Carroll
- 1
Jill Carroll Trading Performance
GuruFocus tracks the stock performance after each of Jill Carroll's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jill Carroll is -38.63%. GuruFocus also compares Jill Carroll's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jill Carroll within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jill Carroll's insider trading performs compared to the benchmark.
Performance of Jill Carroll
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.94 |  | | | | |
| Relative Return to S&P 500(%) | -3.35 | | | | | |
Jill Carroll Ownership Network
Jill Carroll Owned Company Details
What does Pandion Therapeutics Inc do?
Who are the key executives at Pandion Therapeutics Inc?
Jill Carroll is the director & 10 percent owner of Pandion Therapeutics Inc. Other key executives at Pandion Therapeutics Inc include director & 10 percent owner Daniel J. Becker , 10 percent owner Mva Investors, Llc , and 10 percent owner Polaris Partners VIII, L.P. .
Pandion Therapeutics Inc (PAND) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pandion Therapeutics Inc Insider Transactions
Jill Carroll Mailing Address
Above is the net worth, insider trading, and ownership report for Jill Carroll. You might contact Jill Carroll via mailing address: C/o Applied Genetic Technologies Corp., 11801 Research Drive, Suite D, Alachua Fl 32615.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
